Tamás Szerafin

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys et al. · The Lancet · 2019 · 618 citations · Full text

Percutaneous Coronary Intervention, Controlled Syntax Trial, Endovascular Technique +8

Increased Cyclooxygenase-2 Expression and Prostaglandin-Mediated Dilation in Coronary Arterioles of Patients With Diabetes Mellitus

Tamás Szerafin, Nóra Erdei, Tibor Fülöp et al. · Circulation Research · 2006 · 114 citations · Full text

Vascular Disease, Heart Failure, Prostaglandin-mediated Dilation +20

Potential Role of H-Ferritin in Mitigating Valvular Mineralization

Katalin Éva Sikura, László Potor, Tamás Szerafin et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2019 · 69 citations · Full text

Alpha-Gal Specific IgG Immune Response after Implantation of Bioprostheses

Andreas Mangold, Tamás Szerafin, Konrad Höetzenecker et al. · The Thoracic and Cardiovascular Surgeon · 2009 · 62 citations · Full text

New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) II: Albumin Suppresses Angiotensin Converting Enzyme (ACE) Activity in Human

Miklós Fagyas, Úri Katalin, Ivetta Mányiné Siket et al. · PLoS ONE · 2014 · 56 citations · Full text